(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies...
Stats | |
---|---|
Today's Volume | 54 588.00 |
Average Volume | 221 498 |
Market Cap | 12.50M |
EPS | $0 ( 2024-03-28 ) |
Next earnings date | ( $-0.570 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.620 |
ATR14 | $0.0120 (0.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Church Jeffrey Wayne | Buy | 25 000 | Stock Option (Right to Buy) |
2024-03-15 | Anwer Khursheed | Buy | 25 000 | Stock Option (Right to Buy) |
2024-03-15 | Tardugno Michael H | Buy | 12 500 | Stock Option (Right to Buy) |
2024-03-15 | Fritz Frederick J. | Buy | 3 500 | Stock Option (Right to Buy) |
2024-03-15 | Braun Donald P | Buy | 3 500 | Option to purchase Imunon common stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 4 727 667 | Sell: 160 000 |
Volume Correlation
Imunon, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Imunon, Inc. Correlation - Currency/Commodity
Imunon, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-720 005 (0.00 %) |
EPS: | $-2.16 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-720 005 (0.00 %) |
EPS: | $-2.16 |
FY | 2022 |
Revenue: | $500 000 |
Gross Profit: | $-231 629 (-46.33 %) |
EPS: | $-5.03 |
FY | 2021 |
Revenue: | $500 000 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.83 |
Financial Reports:
No articles found.
Imunon, Inc.
Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators